The extraordinary general meeting of Aurobindo Pharma Limited has approved a move to issue shares to Qualified Institutional Buyers up to an amount of $350 million.
The company in a statement to the BSE informed that the approval to issue shares under Qualified Institutional Placement (QIP) was secured at a meeting held on Wednesday.